300138.SZ
晨光生物
SZSE · Consumer Defensive · C 制造业 · CN
CNY 10.96
−0.18%Margins
Gross margin
13.0%
EBITDA margin
9.6%
EBIT margin
6.5%
Net margin
5.5%
FCF margin
-2.7%
10.3%
Return on equity
3.2%
Return on assets
4.6%
Return on invested capital
0.63x
Asset turnover
-CNY 40.7M
Cash from operations
—
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Mar 1, 2026